PNC Financial Services Group’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.66K Sell
1,480
-2,431
-62% -$2.72K ﹤0.01% 4469
2025
Q1
$3.09K Buy
3,911
+3,464
+775% +$2.74K ﹤0.01% 4218
2024
Q4
$738 Buy
447
+13
+3% +$21 ﹤0.01% 4479
2024
Q3
$1.52K Hold
434
﹤0.01% 4347
2024
Q2
$1.42K Hold
434
﹤0.01% 4348
2024
Q1
$3.19K Sell
434
-100
-19% -$734 ﹤0.01% 4081
2023
Q4
$2K Sell
534
-382
-42% -$1.43K ﹤0.01% 4188
2023
Q3
$1.94K Sell
916
-2,100
-70% -$4.45K ﹤0.01% 4251
2023
Q2
$14.4K Buy
3,016
+2,874
+2,024% +$13.7K ﹤0.01% 3707
2023
Q1
$809 Sell
142
-8,115
-98% -$46.2K ﹤0.01% 4465
2022
Q4
$83.3K Sell
8,257
-1,140
-12% -$11.5K ﹤0.01% 2691
2022
Q3
$211K Sell
9,397
-948
-9% -$21.3K ﹤0.01% 2056
2022
Q2
$257K Buy
10,345
+3,608
+54% +$89.6K ﹤0.01% 1974
2022
Q1
$260K Buy
6,737
+986
+17% +$38.1K ﹤0.01% 2094
2021
Q4
$336K Buy
5,751
+1,700
+42% +$99.3K ﹤0.01% 1947
2021
Q3
$240K Buy
4,051
+18
+0.4% +$1.07K ﹤0.01% 2071
2021
Q2
$351K Buy
4,033
+800
+25% +$69.6K ﹤0.01% 1856
2021
Q1
$267K Buy
3,233
+1,363
+73% +$113K ﹤0.01% 2004
2020
Q4
$171K Sell
1,870
-3,560
-66% -$326K ﹤0.01% 2158
2020
Q3
$216K Hold
5,430
﹤0.01% 1880
2020
Q2
$186K Sell
5,430
-370
-6% -$12.7K ﹤0.01% 1973
2020
Q1
$128K Sell
5,800
-3,080
-35% -$68K ﹤0.01% 2070
2019
Q4
$174K Sell
8,880
-2,500
-22% -$49K ﹤0.01% 2149
2019
Q3
$176K Buy
11,380
+520
+5% +$8.04K ﹤0.01% 2207
2019
Q2
$220K Hold
10,860
﹤0.01% 2107
2019
Q1
$190K Sell
10,860
-2,780
-20% -$48.6K ﹤0.01% 2174
2018
Q4
$176K Buy
13,640
+4,260
+45% +$55K ﹤0.01% 2136
2018
Q3
$152K Sell
9,380
-1,140
-11% -$18.5K ﹤0.01% 2344
2018
Q2
$120K Buy
+10,520
New +$120K ﹤0.01% 2481
2014
Q2
Sell
-1,000
Closed -$10K 3837
2014
Q1
$10K Hold
1,000
﹤0.01% 3060
2013
Q4
$6K Buy
+1,000
New +$6K ﹤0.01% 3096